ImmunoGen, Inc. (IMGN): Price and Financial Metrics

IMGN POWR Grades

• IMGN scores best on the Value dimension, with a Value rank ahead of 75.08% of US stocks.
• IMGN's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
• IMGN's current lowest rank is in the Momentum metric (where it is better than 9.5% of US stocks).

IMGN Stock Summary

• Of note is the ratio of ImmunoGen Inc's sales and general administrative expense to its total operating expenses; merely 10.77% of US stocks have a lower such ratio.
• The ratio of debt to operating expenses for ImmunoGen Inc is higher than it is for about just 14.87% of US stocks.
• As for revenue growth, note that IMGN's revenue has grown 58.05% over the past 12 months; that beats the revenue growth of 88.95% of US companies in our set.
• Stocks that are quantitatively similar to IMGN, based on their financial statements, market capitalization, and price volatility, are WVE, MGNX, ABUS, PTGX, and IDYA.
• Visit IMGN's SEC page to see the company's official filings. To visit the company's web site, go to www.immunogen.com.

IMGN Valuation Summary

• In comparison to the median Healthcare stock, IMGN's price/earnings ratio is 160% lower, now standing at -21.9.
• IMGN's price/earnings ratio has moved up 60.5 over the prior 243 months.
• IMGN's EV/EBIT ratio has moved up 60 over the prior 243 months.

Below are key valuation metrics over time for IMGN.

IMGN Growth Metrics

• Its year over year price growth rate is now at 58.01%.
• The 3 year net income to common stockholders growth rate now stands at -34.48%.
• The 3 year net cashflow from operations growth rate now stands at 11.46%.

Over the past 33 months, IMGN's revenue has gone up $57,163,000.

The table below shows IMGN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	136.641	-110.612	-55.778
2021-03-31	134.718	-94.926	-49.335
2020-12-31	132.299	-78.62	-44.372
2020-09-30	91.365	-119.712	-70.946
2020-06-30	86.457	-124.065	-70.322
2020-03-31	86.974	-126.885	-89.47

IMGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IMGN has a Quality Grade of C, ranking ahead of 31.09% of graded US stocks.
• IMGN's asset turnover comes in at 0.437 -- ranking 105th of 677 Pharmaceutical Products stocks.
• RMTI, PTE, and GILD are the stocks whose asset turnover ratios are most correlated with IMGN.

The table below shows IMGN's key quality metrics over time.